Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Cancer Research|January 4, 2008
Is B-Raf a good therapeutic target for melanoma and other malignancies?SubbaRao V Madhunapantula, Gavin P Robertson
Cancer Research|November 10, 2012
Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concernsSanjay Singh, Arati Sharma, Gavin P Robertson
Gene|November 27, 2004
A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancersShuwen Wang, Gavin P Robertson, Jiyue Zhu
Cancer Letters|October 25, 2016
Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growthRaghavendra Gowda, Arati Sharma, Gavin P Robertson
Expert Opinion on Drug Metabolism & Toxicology|November 22, 2011
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systemsArati Sharma, SubbaRao V Madhunapantula, Gavin P Robertson
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Positional approaches to cancer geneticsGavin P Robertson, Linda Sargent, Mark A Nelson
Cancer Biology & Therapy|October 12, 2010
Steroid hormones drive cancer developmentSubbaRao V Madhunapantula, Paul Mosca, Gavin P Robertson
Cancer Research|April 19, 2007
PRAS40 deregulates apoptosis in malignant melanomaSubbaRao V Madhunapantula, Arati Sharma, Gavin P Robertson
The Journal of Biological Chemistry|June 29, 2006
Rheb inhibits C-raf activity and B-raf/C-raf heterodimerizationMagdalena Karbowniczek, Gavin P Robertson, Elizabeth Petri Henske
Molecular Cancer Research : MCR|June 18, 2015
Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 PathwayGregory R Kardos, Hannah C Wastyk, Gavin P Robertson
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Cancer Research|January 4, 2008
Is B-Raf a good therapeutic target for melanoma and other malignancies?SubbaRao V Madhunapantula, Gavin P Robertson
Cancer Research|November 10, 2012
Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concernsSanjay Singh, Arati Sharma, Gavin P Robertson
Gene|November 27, 2004
A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancersShuwen Wang, Gavin P Robertson, Jiyue Zhu
Cancer Letters|October 25, 2016
Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growthRaghavendra Gowda, Arati Sharma, Gavin P Robertson
Expert Opinion on Drug Metabolism & Toxicology|November 22, 2011
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systemsArati Sharma, SubbaRao V Madhunapantula, Gavin P Robertson
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Positional approaches to cancer geneticsGavin P Robertson, Linda Sargent, Mark A Nelson
Cancer Biology & Therapy|October 12, 2010
Steroid hormones drive cancer developmentSubbaRao V Madhunapantula, Paul Mosca, Gavin P Robertson
Cancer Research|April 19, 2007
PRAS40 deregulates apoptosis in malignant melanomaSubbaRao V Madhunapantula, Arati Sharma, Gavin P Robertson
The Journal of Biological Chemistry|June 29, 2006
Rheb inhibits C-raf activity and B-raf/C-raf heterodimerizationMagdalena Karbowniczek, Gavin P Robertson, Elizabeth Petri Henske
Molecular Cancer Research : MCR|June 18, 2015
Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 PathwayGregory R Kardos, Hannah C Wastyk, Gavin P Robertson
Pageof 12